Paola Della Torre

University of Pennsylvania — United States

Medicine · Health Sciences

17h-index748citations26works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chemotherapy-induced cardiotoxicity and mitigation(10), Cancer Treatment and Pharmacology(6), Bacterial Genetics and Biotechnology(2), Cardiac electrophysiology and arrhythmias(2), Lipid Membrane Structure and Behavior(2)

Publications26 total

Direct Visualization of Vesicle Disassembly and Reassembly Using Photocleavable Dendrimers Elucidates Cargo Release Mechanisms
ACS Nano·2020· 40 cited
Encapsulation of hydrophobic components in dendrimersomes and decoration of their surface with proteins and nucleic acids
Proceedings of the National Academy of Sciences·2019· 52 citedOpen Access
Genetically encoded division machinery for cell free synthetic biology
Unitn-eprints PhD (University of Trento)·2018Open Access
Ethylene-Producing Bacteria That Ripen Fruit
ACS Synthetic Biology·2014· 33 citedOpen Access
Multiphase Water-in-Oil Emulsion Droplets for Cell-Free Transcription–Translation
Langmuir·2014· 106 citedOpen Access
Tolerability and toxicological profile of pixantrone (Pixuvri®) in juvenile mice. Comparative study with doxorubicin
Reproductive Toxicology·2014· 21 cited
The Encapsulation of Cell-free Transcription and Translation Machinery in Vesicles for the Construction of Cellular Mimics
Journal of Visualized Experiments·2013· 12 cited
Investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) using the Frog Embryo Teratogenesis Assay-Xenopus (FETAX)
Reproductive Toxicology·2008· 32 cited
In vivo and in vitro investigations of the effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos
Reproductive Toxicology·2006· 74 cited
Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.
PubMed·2001· 19 cited
PNU-159548, a novel cytotoxic antitumor agent with a low cardiotoxic potential
Cancer Chemotherapy and Pharmacology·2001· 11 cited
Cardioprotection by dexrazoxane in rats treated with doxorubicin and paclitaxel
Cancer Chemotherapy and Pharmacology·1999· 26 cited
Influence of mutations associated with familial prion-related encephalopathies on biological activity of prion protein peptides
Annals of Neurology·1999· 18 cited
Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane
Cancer Chemotherapy and Pharmacology·1999· 23 cited
Amidation of β‐Amyloid Peptide Strongly Reduced the Amyloidogenic Activity Without Alteration of the Neurotoxicity
Journal of Neurochemistry·1997· 34 cited
Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
PubMed·1996· 67 cited
Long-Lasting Effect of Dexrazoxane Against Anthracycline Cardiotoxicity in Rats
Toxicologic Pathology·1996· 23 cited
Evaluation of 4′-Iodo-4′-Deoxydoxorubicin-Induced Cardiotoxicity in Two Experimental Rat Models
Toxicologic Pathology·1994· 13 cited
The Histopathology of Kidney Changes in Rats and Monkeys Following Intravenous Administration of Massive Doses of FCE 26184, Human Basic Fibroblast Growth Factor
Toxicologic Pathology·1993· 61 cited
Characterization of the toxicity of distamycin derivatives on cancer cell lines and rat heart
Toxicology·1992· 6 cited
page 1 of 2Next →

Frequent Co-authors

Guy Mazué(8), Arturo Podestà(6), Mario Del Tacca(5), Marco Brughera(4), A. R. Imondi(4), Donatella Moneta(4), Romano Danesi(4), Sheref S. Mansy(3), Monica Longo(3), Giovanni Pinciroli(3), Michael J. Iatropoulos(3), Cristiana Agen(3), Nunzia Bernardini(3), Mario Costa(3), Sara Zanoncelli(2), Mariagrazia Riflettuto(2), AnnaMaria Giusti(2), Paolo Colombo(2), Piero Olliaro(2), Qi Xiao(2)